$LPTH

North Run Strategic Opportunities Fund I, LP sold $50.0M of LPTH (indirect holdings)

North Run Strategic Opportunities Fund I, LP sold 3,571,400 indirectly-held shares of LIGHTPATH TECHNOLOGIES INC (LPTH) at $14.00 ($50.00M total) on 2026-06-03.

Original reporting
SEC EDGAR · North Run Strategic Opportunities Fund I, LP
Published Jun 4, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LPTH
Neutral
medium confidence
Mentioned
$LPTH
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LPTHNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale of $50.0M worth of LPTH shares at $14.00/share on June 3, with holdings after the sale of 2,934,828 shares and no pre-arranged 10b5-1 plan.

02

Market read

This is a single, large disclosed sale by a significant holder, which can influence short-term sentiment but lacks accompanying fundamental news.

03

What to watch

The filing is for an indirect holding by a 10% owner fund; traders should check whether other related entities also sold and whether Lightpath has concurrent catalysts (earnings, contracts, guidance).

Relevance 7/10Novelty 5/10Timing: filed June 4, transaction dated June 3

Background

The article is a Form 4 insider transaction disclosure on Lightpath Technologies (LPTH) by North Run Strategic Opportunities Fund I, LP, a director and 10% owner.

Company-level read

Ticker impact

$LPTHNeutralMedium confidence
Context

North Run Strategic Opportunities Fund I, LP sold 3,571,400 shares of Lightpath Technologies at $14.00/share via an open-market sale Form 4.

Expected impact

Near-term sentiment could soften, but follow-through depends on whether other insiders also sell and on Lightpath’s operating catalysts.

Evidence & confidence

The filing discloses sale size, price, and post-transaction holdings, but provides no stated reason or linkage to company performance; absence of a 10b5-1 plan increases interpretive uncertainty.

Market effects

Limited direct read-through to the broader photonics/optics sector because this is a single-holder transaction without company guidance or operational updates.

None indicated.

None indicated.

Counterpoint

The sale could be liquidity-driven or portfolio rebalancing, and the lack of a 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • LIGHTPATH TECHNOLOGIES INC

    Subject of the Form 4 insider transaction disclosure.

  • North Run Strategic Opportunities Fund I, LP

    Director and 10% owner fund that executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LPTHMed

LIGHTPATH TECHNOLOGIES INC (LPTH): Results of Operations and Financial Condition

LIGHTPATH TECHNOLOGIES INC (LPTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 LightPath Technologies Reports Fiscal 2026 Fourth Quarter and Full Year Financial Results Robust Demand for Germanium-Free Optics Drives Meaningful Backlog Growth with Defense and Public Safety Customers ORLANDO, FL – September 10, 2026 – LightPath Technologies , Inc

$LPTHMed

Taiwan Tech Insiders Warn Beijing's Germanium Squeeze Is Hitting Production

Nikkei Asia reports China is restricting germanium and quartz exports to Taiwan, causing supply-chain bottlenecks in aerospace, semiconductor, and optical industries. Taiwanese manufacturers face prolonged lead times and missed delivery schedules. Piper Sandler initiated coverage of LightPath Technologies (LPH) with an 'Overweight' rating and $15 price target, citing its BlackDiamond glass as a germanium alternative.

$LPTHMed

LightPath Technologies Signs Definitive Agreement to Divest China Operations

LightPath Technologies (NASDAQ: LPTH) said it signed a definitive deal to sell its wholly owned China subsidiary, LPOIZ, including its manufacturing facility and operations in China, to an entity owned by incumbent management. The price is $4.5 million paid in installments over five years. LightPath expects the deal to close soon, with China revenue of about $4.5 million annually (preliminary) deconsolidated.

$LPTHMedAI 8/10

LightPath Technologies shares climb after securing $11 million infrared camera contract (LPTH)

LightPath Technologies (NASDAQ:LPTH) shares rose about 9% after the company said it received an $11 million follow-on order for infrared camera systems for counter-UAS applications, according to the company. The program includes a transition from Germanium optics to LightPath’s BlackDiamond optical materials. The contract is subject to standard purchasing terms and existing agreements.